Sanofi

[PARIS] Sanofi agreed to buy Dynavax Technologies for about US$2.2 billion to expand its vaccines business with a shot for hepatitis B and an experimental shingles inoculation.

[WASHINGTON] President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash US prescription drug prices to match those paid overseas, the White...

The French drugmaker will pay US$1.15 billion upfront with a commitment for potential milestones worth as much as US$450 million

The acquisition represents a strategic step forward in the French drugmaker’s rare and immunology portfolios

Earnings per share, excluding some items, are likely to increase by a low double-digit percentage at constant currencies in 2025, says the French drugmaker

China is seeking to strengthen economic ties with individual members of the European Union

Modulus can also be reconfigured within a few days to transform between technological platforms, a process which traditionally takes months or years

Earnings per share excluding some items reached 2.86 euros in Q3

Sanofi agreed on terms of the deal after providing Paris with guarantees on maintaining jobs and production in France